The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Greenberg Norman Michael since 2020.
This trader's CIK number is 1773750.
At the time of last reporting, Greenberg Norman Michael was the Chief Scientific Officer of Atreca, Inc.. (stock ticker symbol BCEL).
Also see all insider trading activities at Atreca, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | BCEL | 0 | $0 | 15,000 | $254,445 | 15,000 | $75,900 |
| 2020 | BCEL | 0 | $0 | 115,272 | $2,124,319 | 115,272 | $525,633 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-17 | BCEL | Option Ex | 5,000 | 4.86 | 24,300 |
| 2021-03-17 | BCEL | Sale | 5,000 | 16.73 | 83,650 |
| 2021-02-17 | BCEL | Option Ex | 5,000 | 5.16 | 25,800 |
| 2021-02-17 | BCEL | Sale | 5,000 | 18.95 | 94,750 |
| 2021-01-19 | BCEL | Sale | 5,000 | 15.21 | 76,045 |
| 2021-01-19 | BCEL | Option Ex | 5,000 | 5.16 | 25,800 |
| 2020-12-17 | BCEL | Sale | 5,000 | 16.61 | 83,050 |
| 2020-12-17 | BCEL | Option Ex | 5,000 | 4.56 | 22,799 |
| 2020-11-27 | BCEL | Sale | 3,175 | 15.35 | 48,720 |
| 2020-11-27 | BCEL | Option Ex | 3,175 | 4.56 | 14,477 |
| 2020-11-17 | BCEL | Option Ex | 1,825 | 4.56 | 8,322 |
| 2020-11-17 | BCEL | Sale | 1,825 | 15.04 | 27,448 |
| 2020-11-10 | BCEL | Sale | 4,500 | 15.10 | 67,963 |
| 2020-11-10 | BCEL | Option Ex | 4,500 | 4.56 | 20,520 |
| 2020-10-19 | BCEL | Sale | 500 | 15.12 | 7,562 |
| 2020-10-19 | BCEL | Option Ex | 500 | 4.56 | 2,280 |
| 2020-07-01 | BCEL | Option Ex | 10,272 | 4.56 | 46,840 |
| 2020-07-01 | BCEL | Sale | 10,272 | 21.93 | 225,285 |
| 2020-06-01 | BCEL | Option Ex | 15,000 | 4.56 | 68,400 |
| 2020-06-01 | BCEL | Sale | 15,000 | 18.38 | 275,760 |
| 2020-05-07 | BCEL | Option Ex | 5,000 | 4.56 | 22,799 |
| 2020-05-07 | BCEL | Sale | 5,000 | 18.00 | 90,000 |
| 2020-05-01 | BCEL | Sale | 10,000 | 15.03 | 150,280 |
| 2020-05-01 | BCEL | Option Ex | 10,000 | 4.56 | 45,599 |
| 2020-04-14 | BCEL | Sale | 5,000 | 18.00 | 90,000 |
| 2020-04-14 | BCEL | Option Ex | 5,000 | 4.56 | 22,799 |
| 2020-04-08 | BCEL | Option Ex | 8,000 | 4.56 | 36,480 |
| 2020-04-08 | BCEL | Sale | 8,000 | 15.01 | 120,104 |
| 2020-04-01 | BCEL | Sale | 2,000 | 15.21 | 30,422 |
| 2020-04-01 | BCEL | Option Ex | 2,000 | 4.56 | 9,120 |
| 2020-03-02 | BCEL | Option Ex | 15,000 | 4.56 | 68,400 |
| 2020-03-02 | BCEL | Sale | 15,000 | 24.50 | 367,500 |
| 2020-02-03 | BCEL | Option Ex | 15,000 | 4.56 | 68,400 |
| 2020-02-03 | BCEL | Sale | 15,000 | 19.72 | 295,860 |
| 2020-01-24 | BCEL | Option Ex | 5,000 | 4.56 | 22,799 |
| 2020-01-24 | BCEL | Sale | 5,000 | 18.47 | 92,345 |
| 2020-01-17 | BCEL | Option Ex | 10,000 | 4.56 | 45,599 |
| 2020-01-17 | BCEL | Sale | 10,000 | 15.20 | 152,020 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenberg Norman Michael (Chief Scientific Officer of Atreca, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.